NZ232826A - Leukaemia inhibitory factor (lif) and its effects on bone metabolism - Google Patents
Leukaemia inhibitory factor (lif) and its effects on bone metabolismInfo
- Publication number
- NZ232826A NZ232826A NZ232826A NZ23282690A NZ232826A NZ 232826 A NZ232826 A NZ 232826A NZ 232826 A NZ232826 A NZ 232826A NZ 23282690 A NZ23282690 A NZ 23282690A NZ 232826 A NZ232826 A NZ 232826A
- Authority
- NZ
- New Zealand
- Prior art keywords
- lif
- effects
- inhibitory factor
- bone metabolism
- leukaemia inhibitory
- Prior art date
Links
- 230000004097 bone metabolism Effects 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
- 208000032839 leukemia Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/20—Interleukins [IL]
- A61K38/2093—Leukaemia inhibitory factor [LIF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Nutrition Science (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPJ309189 | 1989-03-07 | ||
| AUPJ474289 | 1989-06-15 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ232826A true NZ232826A (en) | 1992-09-25 |
Family
ID=25643646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ232826A NZ232826A (en) | 1989-03-07 | 1990-03-07 | Leukaemia inhibitory factor (lif) and its effects on bone metabolism |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0463004A4 (xx) |
| JP (1) | JP3055802B2 (xx) |
| CA (1) | CA2048673A1 (xx) |
| NZ (1) | NZ232826A (xx) |
| WO (1) | WO1990010454A1 (xx) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL97779A (en) * | 1990-04-10 | 2000-01-31 | Genentech Inc | Compositions for cytoprotection against radiation and chemotherapy injury or risk thereof |
| WO1994021272A1 (en) * | 1993-03-17 | 1994-09-29 | Amrad Corporation Limited | A method for treating microbial infection in an animal by administering a composition comprising lif and a cytokine |
| DE60009525T2 (de) * | 1999-09-30 | 2005-02-03 | Kaken Pharmaceutical Co., Ltd. | Herstellung eines medikamentes zur verbesserten heilung des sternums nach einer sternotomie |
| US10512708B2 (en) | 2013-03-07 | 2019-12-24 | Case Western Reserve University | Bioadhesive hydrogels |
| US11273236B2 (en) | 2016-09-07 | 2022-03-15 | Case Western Reserve University | Engineered tissue constructs |
| EP3551199A4 (en) * | 2016-12-11 | 2020-07-22 | Case Western Reserve University | COMPOSITIONS AND METHODS OF MODULATION OF ENDOCHONDRAL OSSIFICATION AND BONE FORMATION |
| WO2019040224A1 (en) | 2017-08-21 | 2019-02-28 | Case Western Reserve University | HYDROGEL FOR TISSUE ENGINEERING AND BIO-PRINTING |
| US20190298883A1 (en) | 2018-03-30 | 2019-10-03 | Case Western Reserve University | Insoluble native collagen fibers and their use in cell aggregates and tissue constructs |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4438032A (en) * | 1981-01-30 | 1984-03-20 | The Regents Of The University Of California | Unique T-lymphocyte line and products derived therefrom |
| US4675295A (en) * | 1981-10-28 | 1987-06-23 | Denki Kagaku Kogyo Kabushiki Kaisha | Process for producing subculturable lymphokine-producing human T cell hybridomas |
| AU609128B2 (en) * | 1987-04-02 | 1991-04-26 | Amrad Operations Pty. Limited | Leukaemia-inhibitory factor |
-
1990
- 1990-03-06 CA CA002048673A patent/CA2048673A1/en not_active Abandoned
- 1990-03-06 JP JP2504497A patent/JP3055802B2/ja not_active Expired - Fee Related
- 1990-03-06 EP EP19900904185 patent/EP0463004A4/en not_active Withdrawn
- 1990-03-06 WO PCT/AU1990/000092 patent/WO1990010454A1/en not_active Ceased
- 1990-03-07 NZ NZ232826A patent/NZ232826A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP3055802B2 (ja) | 2000-06-26 |
| JPH04503958A (ja) | 1992-07-16 |
| EP0463004A4 (en) | 1992-04-01 |
| WO1990010454A1 (en) | 1990-09-20 |
| EP0463004A1 (en) | 1992-01-02 |
| CA2048673A1 (en) | 1990-09-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB8830152D0 (en) | Cooled turbomachinery components | |
| EP0285448A3 (en) | Leukaemia inhibitory factor | |
| GB8904696D0 (en) | Electronic locker system | |
| HU903399D0 (en) | Cryosurgical device | |
| DK0387885T3 (da) | Direkte kompressionscholostyramintablet og opløsningsmiddelfri coating dertil | |
| EP0414405A3 (en) | Aligned slideholder and slide assembly | |
| NZ232826A (en) | Leukaemia inhibitory factor (lif) and its effects on bone metabolism | |
| IL93708A (en) | Joule-thomson cooler | |
| EP0415246A3 (en) | Electronic rack | |
| GB9004890D0 (en) | Leukaemia inhibitory factor | |
| GB9018760D0 (en) | Integrated circuit and its connecting circuit | |
| EP0421603A3 (en) | Melt-processable copolyesterimide | |
| GB2216180B (en) | Cabinet | |
| GB9003629D0 (en) | Jig and jig arrangement | |
| AU6282090A (en) | Analog multiplying-averaging circuit and wattmeter circuit using the circuit | |
| GB2236203B (en) | Calculation method and calculator using the same | |
| ZA901746B (en) | Metabolic effects of leukaemia inhibitory factor on bone | |
| GB2231408B (en) | Sampling circuits | |
| GB2214743B (en) | Sample and hold circuit | |
| GB8919861D0 (en) | Shelf | |
| GB2259635B (en) | Oscilloscope | |
| ZA911096B (en) | (2-imidazolin-2-ylamino)tetrahydro-quinoxalines and methods for using same | |
| GB2226726B (en) | Sample and hold circuit | |
| ZA882277B (en) | Leukaemia inhibitory factor | |
| IE891418L (en) | Fluoroavermectins and fluoromilbemycins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) |